argenx SE reported $427M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
AstraZeneca USD 5.16B 510M Jun/2026
Genmab DKK 186M 291M Dec/2025
GlaxoSmithKline GBP 3.51B 734M Jun/2026
GRIFOLS EUR 473M 120M Jun/2026
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lakefront Biotherapeutics EUR -63.7M 624.2M Mar/2026
Qiagen NV USD 148.09M 101.6M Mar/2026
UCB EUR 1.6B 570M Dec/2025